This hydrophobic interaction medium is designed for purification of hepatitis B vaccine components. It uses a four-percent agarose gel matrix functionalized with butyl ligands. Target molecules bind through hydrophobic interactions under suitable high-salt conditions. Reducing ionic strength releases bound components according to their hydrophobicity. The spherical particles provide uniform packing and stable separation performance. Protein adsorption above 26 mg BSA/mL supports preparative purification. The medium operates at 70-140 cm/h under the specified pressure condition. Broad pH stability allows repeated cleaning-in-place. The matrix can withstand the stated steam-treatment conditions in sodium chloride solution.
Specification
Model: Butyl Seplife 4B Appearance: White spherical gel Matrix: 4% agarose gel Ligand: Butyl Shape: Spherical Particle size: 45-165 µm Pressure-flow range: 70-140 cm/h at 0.15 MPa Protein adsorption capacity:>26 mg BSA/mL Operating temperature: 4-40°C Long-term pH stability: 3-13 Short-term CIP pH stability: 2-14 Chemical compatibility: Common aqueous buffers, 1 mol/L sodium hydroxide, 70% ethanol, 50% ethylene glycol, 8 M urea, 6 mol/L guanidine hydrochloride, and 1 mM hydrochloric acid Heat resistance: 121°C in 0.1 M sodium chloride for 30 min
Features
Hepatitis B vaccine application Butyl interaction chemistry >26 mg/mL BSA capacity Broad chemical stability Steam-tolerant matrix Wide CIP pH range Uniform agarose particles Mild hydrophobic purification